Our company operates to the highest international standards of quality. Our teams are committed to delivering a quality service at each stage of a process from development through to commercial manufacturing, delivering high-quality products at all times.
Quality by Design techniques and the effective use of formal risk management processes are used to define and steer a compliant product strategy that controls and mitigates risk.
Our facilities are regularly inspected by national and international regulatory authorities as well as our clients.
Our policies support our clients' active involvement to ensure that no risk occurs in the process of bringing new drugs to market.
Our highly experienced team can offer complete API regulatory support from initial submission to market authorization:
© 2023 Dishman Carbogen Amcis Ltd - All Rights Reserved